-
2-hydroxypropane-1,2,3-tricarboxylic acid; {2-[4-(4-chloro-1,2-diphenylbut-1-en-1-yl)phenoxy]ethyl}dimethylamine
-
ChemBase ID:
154596
-
Molecular Formular:
C32H36ClNO8
-
Molecular Mass:
598.08314
-
Monoisotopic Mass:
597.2129448
-
SMILES and InChIs
SMILES:
CN(C)CCOc1ccc(cc1)/C(=C(\CCCl)/c1ccccc1)/c1ccccc1.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
Canonical SMILES:
OC(=O)CC(C(=O)O)(CC(=O)O)O.ClCC/C(=C(/c1ccccc1)\c1ccc(cc1)OCCN(C)C)/c1ccccc1
InChI:
InChI=1S/C26H28ClNO.C6H8O7/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-16H,17-20H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
InChIKey:
IWEQQRMGNVVKQW-UHFFFAOYSA-N
-
Cite this record
CBID:154596 http://www.chembase.cn/molecule-154596.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
2-hydroxypropane-1,2,3-tricarboxylic acid; {2-[4-(4-chloro-1,2-diphenylbut-1-en-1-yl)phenoxy]ethyl}dimethylamine
|
|
|
IUPAC Traditional name
|
citro; {2-[4-(4-chloro-1,2-diphenylbut-1-en-1-yl)phenoxy]ethyl}dimethylamine
|
|
|
Synonyms
|
(Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine
|
Acapodene
|
Fareston
|
GTx 006
|
Z-Toremifene
|
Toremifene citrate salt
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
H Acceptors
|
2
|
H Donor
|
0
|
LogD (pH = 5.5)
|
3.2030618
|
LogD (pH = 7.4)
|
4.8896103
|
Log P
|
6.269135
|
Molar Refractivity
|
133.4105 cm3
|
Polarizability
|
48.227203 Å3
|
Polar Surface Area
|
12.47 Å2
|
Rotatable Bonds
|
14
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
T7204
|
Biochem/physiol Actions Toremifene citrate is an oral selective estrogen receptor modulator (SERM). Toremifene citrate is used in advanced (metastatic) breast cancer and being evaluated for prevention of prostate cancer. |
PATENTS
PATENTS
PubChem Patent
Google Patent